Entyvio 300 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26FCZC7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $48,807
Award facts
- Contract value 100% obligated
- $48,806.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $48.8K to DMS Pharmaceutical Group Inc. for ENTYVIO 300 mg vials, a specialty biologic pharmaceutical. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was awarded this firm fixed-price delivery order on December 19, 2025, with an ultimate completion date of December 22, 2025. The contract carries no set-aside designation, indicating the vendor competed in the open market. The place of performance is located in Park Ridge, Illinois.
This delivery order operates under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.9M single-award contract established on November 13, 2025. The PPV-G GEN V represents part of a $30.3B acquisition strategy designed to supply pharmaceutical products and medical consumables to Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its capability to fulfill specialized pharmaceutical requirements for military medical operations globally.
Quick answers
Who was awarded contract SPE2DR26FCZC7?
SPE2DR26FCZC7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26FCZC7 worth?
The government has obligated $48,807 on SPE2DR26FCZC7.
Is contract SPE2DR26FCZC7 an order under another contract?
Yes. SPE2DR26FCZC7 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCZC7 competed?
The extent of competition for SPE2DR26FCZC7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award